by Eric Christianson | May 17, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
If you follow geriatrics or are board-certified, you probably know that nortriptyline is generally preferred over amitriptyline in this patient population. It’s kind of weird to think there is such a difference because nortriptyline is an active metabolite of...
by Eric Christianson | May 13, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Selective serotonin reuptake inhibitors (SSRIs) are among the most frequently prescribed medication classes in clinical practice. While they are generally considered safe and effective, clinicians should remain aware of several important drug interactions that can...
by Eric Christianson | May 10, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Seasonal affective disorder (SAD) presents a unique opportunity in psychiatric prescribing because, unlike many other mood disorders, the timing of symptoms is often predictable. Patients typically experience depressive symptoms during the fall and winter months, with...
by Eric Christianson | May 6, 2026 | Polypharmacy Cases And The Prescribing Cascade
If I had 60 seconds to review a med list, I wouldn’t try to analyze every detail. That’s the biggest mistake clinicians make when time is limited. Instead, I rely on pattern recognition—quickly scanning for a handful of high-yield problem areas that consistently lead...
by Eric Christianson | May 3, 2026 | Polypharmacy Cases And The Prescribing Cascade
I’ve been collecting examples of situations where a patient is “stable”, and a provider doesn’t want to change medications. Stable is good, right? It is, but it can also lead to providers not wanting to reduce medications and change anything....
